Patient-Reported Outcome Improvement with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program

被引：0
|
作者：
Hudesman, David [1 ]
Torres, Joana [2 ]
Salese, Leonardo [3 ]
Woolcott, John C. [3 ]
Mundayat, Rajiv [4 ]
Su, Chinyu [3 ]
Mosli, Mahmoud H. [5 ]
Allegretti, Jessica R. [6 ]
机构：
[1] NYU, Sch Med, New York, NY 10003 USA
[2] Hosp Beatriz Angelo, Lisbon, Portugal
[3] Pfizer Inc, Collegeville, PA USA
[4] Pfizer Inc, New York, NY USA
[5] King Abdulaziz Univ Hosp, Jeddah, Makkah, Saudi Arabia
[6] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S866
引用
收藏
页码：S403 / S404
页数：2
相关论文
共 50 条
  • [1] Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program
    Hudesman, David P.
    Torres, Joana
    Salese, Leonardo
    Woolcott, John C.
    Mundayat, Rajiv
    Su, Chinyu
    Mosli, Mahmoud H.
    Allegretti, Jessica R.
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2023, 16 (02): : 95 - 103
  • [2] Long-Term Improvement in the Patient-Reported Outcomes of Rectal Bleeding, Stool Frequency, and Health-Related Quality of Life with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program
    David P. Hudesman
    Joana Torres
    Leonardo Salese
    John C. Woolcott
    Rajiv Mundayat
    Chinyu Su
    Mahmoud H. Mosli
    Jessica R. Allegretti
    [J]. The Patient - Patient-Centered Outcomes Research, 2023, 16 : 95 - 103
  • [3] Assessment of Health-Related Quality of Life and Patient-Reported Outcomes With Tofacitinib Treatment Stratified by Age in Patients From the OCTAVE Ulcerative Colitis Clinical Program
    Dubinsky, Marla C.
    Biedermann, Luc
    Hart, Ailsa
    Panes, Julian
    Rubin, David T.
    Fellmann, Marc
    Gardiner, Sean
    Paulissen, Jerome
    Almadi, Majid A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S741 - S742
  • [4] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE TOFACITINIB OCTAVE ULCERATIVE COLITIS CLINICAL PROGRAM
    Vermeire, Severine
    Armuzzi, Alessandro
    Kwok, Kenneth K.
    Lawendy, Nerrvin
    Woolcott, John
    Salese, Leonardo
    Su, Chinyu
    Hudesman, David
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S353 - S353
  • [5] IMPROVEMENT IN PATIENT-REPORTED INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE OUTCOMES, AND RELATIONSHIP WITH DISEASE ACTIVITY, IN TOFACITINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS: DATA FROM THE OCTAVE CLINICAL TRIALS
    Dubinsky, Marla
    Bressler, Brian
    Armuzzi, Alessandro
    Salese, Leonardo
    DiBonaventura, Marco d.
    Maller, Eric S.
    Fan, Haiyun
    Woodworth, Deborah A.
    Su, Chinyu
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1102 - S1102
  • [6] Improvement in patient-reported Inflammatory Bowel Disease Questionnaire outcomes, and relationship with disease activity, in tofacitinib-treated patients with ulcerative colitis: Data from the OCTAVE clinical trials
    Dubinsky, M. C.
    Bressler, B.
    Armuzzi, A.
    Salese, L.
    DiBonaventura, M.
    Maller, E.
    Fan, H.
    Woodworth, D. A.
    Su, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2019, 13 : S462 - S463
  • [7] TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: ANALYSIS OF INFECTION RATES FROM THE OCTAVE CLINICAL PROGRAM
    Winthrop, Kevin L.
    Loftus, Edward V.
    Baumgart, Daniel C.
    Reinisch, Walter
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Lawendy, Nervin
    Chan, Gary
    Pedersen, Ronald D.
    Friedman, Gary S.
    Su, Chinyu
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S388 - S388
  • [8] TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: ANALYSIS OF MALIGNANCY RATES FROM THE OCTAVE CLINICAL PROGRAM
    Lichtenstein, Gary R.
    Ciorba, Matthew A.
    Rogler, Gerhard
    Quirk, Daniel
    Nduaka, Chudy I.
    Pedersen, Ronald D.
    Lawendy, Nervin
    Chan, Gary
    Su, Chinyu
    Panes, Julian
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S385 - S386
  • [9] Tofacitinib in active ulcerative colitis: Analysis of efficacy based on patient-reported outcomes
    Panes, J.
    Su, C.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Mamolo, C.
    Healey, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S51 - S51
  • [10] Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates in the Tofacitinib Ulcerative Colitis Clinical Program
    Winthrop, Kevin L.
    Loftus, Edward V., Jr.
    Baumgart, Daniel C.
    Salese, Leonardo
    Thorpe, Andrew J.
    Lawendy, Nervin
    Chan, Gary
    Pedersen, Ronald D.
    Reinisch, Walter
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S427 - S429
12345